The results suggested that, after adjustments for tumor purity, the NCBP2 expression was positively associated with all immune cells, including B cells (r = 0.364, p = 3.30 × 10−12), CD8+ T cells (r = 0.295, p = 2.71 × 10−8), CD4+ T cells, (r = 0.484, p = 1.37 × 10−21), macrophages (r = 0.551, p = 1.97 × 10−28), neutrophils (r = 0.457, p = 3.26 × 10−19), and dendritic cells (r = 0.453, p = 1.97 × 10−18) (Figure 8A). The gene discussed is CD8A; the disease is neoplasm.